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Abstract
Background:
Prevalence of  herpes simplex type 2 virus (HSV-2) is high worldwide. Previous studies in Uganda were rural or in women. 
We estimated age and sex-specific sero- prevalence of  HSV-2 in Kampala, Uganda.
Methods: Using two-stage random sampling stratified on population density, a survey of  persons 15-65 years was con-
ducted. Type-specific serological tests for HSV-2, HSV-1(HerpeSelect2 and 1 ELISA), HIV (Rapid tests and ELISA), syphi-
lis  (RPR and TPHA) were done. Additional prevalence analysis included post-stratification weighting on the Uganda 2002 
Census gender distribution.
Results: Among 1124 persons, HSV-2 prevalence was 58% (95% CI: 55, 60), HSV-1; 98% (95% CI: 97.6, 99.1), HIV; 17.7% 
(95% CI: 14.8, 19.2) and syphilis; 1.7% (95% CI: 1.4, 1.9). Weighted HSV-2 prevalence was 53.8% (Women; 63.8%, men; 
43.2%), similar to unweighted data. Weighted HIV prevalence was 20.7% in women, 8.6% in men. Of  165 HIV infected 
persons, 85.4% had HSV-2.   Risk factors for HSV-2 were being a woman (OR 2.0; 95% CI: 1.42, 2.78), age (OR 3.3;
95% CI: 2.43, 4.53), education (OR 1.70; 95% CI: 1.34, 2.34) and HIV (OR 4.5; 95% CI: 2.70, 7.50). 
Conclusion: Prevalence of  HSV-2 and HIV was high especially in women. Syphilis was rare. Awareness of  herpes was low. 
Interventions in young people are needed.
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Introduction
Infection with herpes simplex virus type 1 and 2 (HSV-1 
and 2) is common worldwide1.Estimates of  HSV-2 
prevalence in Africa are high;  78% in women and 
45% in men 2. No vaccine exists to prevent infection. 
HSV-2  infection is closely correlated to and fuels the 
HIV epidemic in sub-Saharan Africa and elsewhere3, 4,5. 
Studies to disrupt this synergy have been unsuccessful6. 
HSV-2 remains an important sexually transmitted dis-
ease (STD); inherently and because of  its synergy with 
HIV.
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Previous studies to assess the prevalence of  HSV-2 in 
Uganda were in rural settings7.At the time this study 
was conducted, there was limited population data on 
prevalence of  HSV-2 infection in Uganda’s urban ar-
eas. Recent studies in Uganda show high prevalence in 
women8,9, pregnant women and  clinical trial popula-
tions 10 but population estimates of  HSV-2 infection  in 
urban Uganda are few.
Materials and Methods
Study design and procedures
From February 2004 to June 2004, we conducted a 
study evaluating the prevalence of  HSV-2 among resi-
dents of  Kawempe Division (one of  five divsions in 
urban Kampala), Uganda. Using two-stage stratified 
random sampling weighted on population density, we 
randomly selected 7 of  18 parishes in Kawempe and 
stratified these 7 on population density. Using detailed 
maps of  all roads in the area from the Uganda Bureau 
of  Statistics, we numbered the mapped road junctions 
in each parish. The road junctions were then randomly 
selected with replacement from a covered box as points 
for starting data collection each morning. The direction 
research assistants took was selected with replacement 
from a box with four directions. We approached people 
in every third housing unit and one consenting person 
was chosen without replacement in every third housing 
unit to enroll.
Enrolled participants were 15 to 65 years old, had lived 
in the area for at least two weeks, and able to give writ-
ten informed consent or assent to the study. 
Participants consented to HSV-2 testing but could opt 
out of  HIV testing. Participants received pre and post 
test HIV counseling and if  HIV positive, given referral 
for care to Mulago National Referral Hospital or clinic 
of  their choice. HSV-2 positive persons with symptoms 
were referred to the STD clinic, reviewed and provided 
with episodic acyclovir treatment during the study.
Trained research assistants obtained consent from eligi-
ble persons prior to confidential interviews and blood 
draws. We used standardized pre-tested questionnaires 
to collect data on socio-demographics, sexual history, 
history of  symptoms related to genital ulcer disease and 
other STDs. Return visits over weekends and evenings 
were conducted but did not change distribution of  men 
enrolled.
A contact address was collected. Consenting partici-
pants provided a sample of  blood (5ml) for laboratory 
testing.
We tested sera for HSV-1 and 2 using type-specific se-
rological tests (HerpeSelect 1 and 2 ELISA.), Focus 
Technologies, California)11. We considered index values 
of  3.5 and above to indicate HSV-2 infection. We ex-
plored the 2.2 cut off  and 1.1 cut off  to describe po-
tential lower limits for prevalence; the manufacturer’s 
cut off  was considered diagnostic for HSV-1 infection. 
HIV was tested using HIV ELISA (HIV ELISA Vi-
ronostika HIV Uni-form II Ag/Ab (BioMerieux Box-
tel, Netherlands).Persons with a positive HIV ELISA 
test received a rapid test (Capillus HIV-1/HIV-2, Trin-
ity Biotech, USA) for confirmation. For those with dis-
cordant results on these two tests, we performed a third 
rapid HIV test (Abbot Determine, Abbott Laboratories 
Abbott Park IL, USA) as a tie breaker. Persons testing 
positive on two of  the tests were considered HIV in-
fected. We tested for syphilis using the RPR Test (Hu-
man GmbH Wiesbaden, Germany) and confirmed with 
TPHA (Syphilis TPHA liquid Test (Human GmbH 
Wiesbaden, Germany). The study was reviewed and 
approved by University Hospitals of  Cleveland Ethi-
cal Review Board, the Joint Clinical Research Center 
(JCRC) Ethical Review Board and the Uganda National 
Council of  Science and Technology.
We  calculated  the  proportion  of   persons  with 
HSV-2  infection  with  95% confidence intervals using 
the 3.5 cut off. We also conducted sensitivity analyses 
for HSV-2 prevalence with the FDA approved cut off  
(1.1 and above) and a 2.2 cut off  suggested in an earlier 
paper with colleagues12 .  The final reported results are 
based  on  the  3.5  cut off   to  increase  specificity13 , 14. 
We  calculated  weighted proportions for HSV-2 and 
HIV infection among women and men to mitigate 
potential bias due to skewed response from wom-
en (70% in study compared to a 51% population 
distribution)15.  We calculated the proportion of  people 
with HSV-1 and syphilis infection with 95% confidence 
intervals. Chi-square tests, F-tests of  significance and 
univariate logistic regression were used to assess socio- 
demographic factors associated with odds of  HSV-2 
infection.   To assess confounding  and  interaction,  we 
built  multivariate  logistic  models  to  include factors 
significant at p<=0.05 on univariate analysis. The mod-
el fit was evaluated using Hosmer-Lemeshow goodness 
of  fit tests. As a sensitivity analysis, we repeated our re-
gression with the HerpeSelect 2 manufacturer’s cut off  
for positivity of  1.1 index value and the 2.2 index value 
but this did not appreciably change the results  (data 
not  shown).  Data  was  analyzed  using  PASW  10.0 
(PASW  Inc, Chicago  IL)  and  SAS  version  9.1 soft-
ware  (SAS  Institute  Inc.  Cary,  North Carolina).
A sample size was generated for each selected stratum 
proportionate to population size. We calculated a sam-
ple size of  1073 persons based on an overall HSV-2 
prevalence of  54%, and for specific age groups 15-19, 
25-29 and  greater than 40 years from prevalence studies 
on HSV-2 in rural Uganda with 5% error and after sam-
ple allocation and weighting for population density16 17.
Results
We enrolled 1124 persons who provided questionnaire 
data and blood samples for the HSV-2 and HSV-1 anti-
body test. 971 persons (85.5%) consented to HIV test-
ing and all but 11 (1%) consented to receiving HIV re-
sults. Enrolled participants included 786 (70 %) women 
and 338 (30 %) men. Median age was 26 years (Inter-
quartile range [IQR] 22 to 33 years). Men and women 
enrolled were similar as regards age (p=0.44).
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Table 1 Unadjusted and Adjusted Models for Correlates of  Prevalent HSV-2 in the Survey Population
 
VARIABLE  N HSV-2 Positive 
n (%) 
Unadjusted Odds           Adjusted Odds 
Ratio                      Ratio (95%CI) 















26+  578 417 (72) 3.47 (2.71 - 4.46)           3.30 (2.43-4.53)* 
Age at first sex     








1.82 (1.36-2.42)             1.07 (0.85-1.36) 
Gender     
Male  338 147 (43) 1.00 (Ref) 
Female  786 503 (64) 2.31 (1.78 - 2.91)           2.00 (1.42-2.78)* 
Education 
> 7years 













   
Open  798 461 (58) 1.00 (Ref) 
One partner  316 182 (58) 1.1 (0.76-1.29)              1.05 (0.69-1.55) 
Duration of     
Partnership     
> 2 years  601 396 (66) 1.00(Ref) 




















1.93 (1.4-2.64)              1.34 (0.97-1.96) 
 
HIV 










Positive  165 141 (85.4) 5.29 (3.3 - 8.3) 4.52 (2.73-7.49)* 
Declined  153    
<10% missing data, * p<0.05
The most common occupation was small business fol-
lowed by housewives (Table 1). 
Students made up 117 (10.4%) and 149 (13.3%) were 
unemployed. More than half  were married (615, 54.7%) 
and in a stable partnership. Nearly half  of  participants 
had a primary education. Men had significantly higher 
education than women (p<0.001) and were more likely 
to have extra marital partners (30% vs 12%).
Women were more likely to have an older sexual partner 
and to have had earlier sexual intercourse. Only 94 per-
sons (8.4%) reported using condoms for every sex act 
in the past thirty days.    Nearly half  reported they used 
condoms rarely in the past thirty days and 52 (5%) had 
not used condoms in the past 30 days. Condom use was 
unusual with regular partners.
Of   1124 participants, 648 (58%, 95% CI: 55,60) tested 
HSV-2 positive using the HerpeSelect 3.5 cut off  (75% 
and 61% tested positive using the 1.1  and 2.2 cut 
off  respectively). Weighted analysis on gender distribu-
tion did not appreciably change the overall and gender 
specific prevalence (57.8 % overall ; 64.0% for women 
and 43.0% for men). Gender specific HSV-2 prevalence 
was similar in the weighted and the un-weighted data. 
Prevalence of  HSV-2 increased with age (36% in the 
15-19 year age group to 85% in the 40 and above age 
group). Women had significantly higher prevalence of  
HSV-2 compared to men (p<0.0001) and the differenc-
es increased with age (Figure 1). 
Figure 1.  Age Specific HSV-2 Prevalence by Gender
A total of  1106 persons (98 %, 95% CI: 97.6, 99.1) 
tested HSV-1 positive. Seventeen percent of  people 
had HIV infection (95% CI: 14.80, 19.15). Men had 
significantly lower HIV prevalence (8.6%) than wom-
en (22%), (p<0.001). On weighting, HIV prevalence 
was 16% (95% CI: 15.87, 16.10), HIV prevalence for 
women was 19.9% and for men 8.4%, similar to the 
un-weighted data. Syphilis in this population was rare at 
1.7% (95% CI: 1.40, 1.90).
On univariate analysis, women were more likely to have 
HSV-2 infection (OR 2.0,95% CI 1.42-2.78) compared 
to men. Age of  participants, age when they first had sex 
, years of  education, condom use with regular partner 
and HIV status were associated with HSV-2 prevalence 
(Table 1). 
Log odds of  HSV-2 infection increased linearly with age 
(p<0.001). Among people who reported use of  con-
doms with their regular partner, people who used con-
doms more often had lower odds of  HSV-2 infection 
(OR  0.5; 95% CI: 0.48-0.64). There was no statistical 
evidence for two way interaction between gender and 
age group; (Breslow Day Test for Homogeneity of  the 
Odds Ratio p=0.11, Mantel-Haenszl Common Odds 
Ratio (MH COR 3.43 ; 95% CI: 2.55, 4.62); between 
age group and HIV status, (Breslow Day Test for Ho-
mogeneity of  the Odds Ratio p=0.73, MH COR 5.18 ; 
95%CI: 2.6,10.1) nor between gender and HIV status  ( 
Breslow Day Test for Homogeneity of  the Odds Ratio 
p=0.33, (MH COR 5.59 ; 95% CI:
2.88,10.81) . 
In the adjusted multivariable logistic model (Table 1), 
risk factors associated with HSV-2 infection were gen-
der (OR 2.0; 95% CI: 1.42, 2.78), being older than 25 
years (OR 3.3; 95% CI: 2.43, 4.53), education level 
(OR 1.70; 95% CI: 1.34, 2.34) for  persons with less 
than7 years of  education and HIV status (OR 4.5; 95% 
CI:2.70, 7.50). 141(14.5%) of  all sample study partici-
pants were dually infected with HSV-2 and HIV. Of  
165 persons infected with HIV, 85.4% also had HSV-2 
infection.  In contrast, among the HIV negative persons 
52.6% (424) had HSV-2 infection. In total, 558 persons 
reported a history of  genital ulcers.
Of  the 648 people who tested HSV-2 positive, 301 
(46.5%) reported history of  ulcers and thought those 
ulcers were due to syphilis infection. However in this 
sample, only 19 people out of  the 1124 (1.69%) tested 
positive for syphilis. Of  these 15 (79%) had HSV-2 in-
fection.
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Discussion
In this population-based survey in Kampala, we found 
high prevalence of  HSV-2 infection (58%), demonstrat-
ing a high burden of  genital herpes in   urban Uganda. 
 
Prevalence among women 20 years and above was sig-
nificantly higher than in men. However, there was simi-
larity in HSV-2 prevalence in the 15 to 19 year age group 
for men and women. Prevalent HIV infection was high 
over all but higher among women. Syphilis was rare but 
many with history of  genital ulcers who tested HSV-
2 positive, reported they thought the ulcers were due 
to syphilis and only rarely due to herpes. Risk factors 
for prevalent HSV-2 infection included being a woman, 
older age, low condom use, younger age at first sex and 
presence of  HIV infection similar to earlier studies.18 
These associations were significant on univariate and 
multivariable analyses, again  similar to several studies 
3. The report shows a high rate of  HSV-2 co-infection 
among HIV infected persons.
To our knowledge, this is one of  the few population 
studies on HSV-2 prevalence and associated risk factors 
in urban Uganda. Prevalence of  HSV-2  was higher than 
in earlier rural population studies in Uganda (Rakai, Ma-
saka) 19, 20. The Uganda national sero-behavioral survey 
done in 2004-5 showed similar prevalence of  HSV-2 
21 with a different a  serological test and low syphilis.. 
Similar HSV-2 prevalence (30-80%) has been reported 
from other urban sub-Saharan locations. For example, 
in urban Zimbabwe HSV-2 prevalence was 68% and in 
Ndola, Zambia 55%.22. In contrast, population-based 
studies found  substantially lower prevalence in Europe 
23 and  Australia. 24. The recent NHANES (2005-2008) 
survey in the US found prevalence of  16.2%.  Howev-
er, the HSV-2 prevalence among non-Hispanic African 
Americans  in that survey was comparable to our study, 
at  56%.25   Similarly high prevalence (54%) has been 
noted in Haiti.
In our study, as in Haiti , Africa and Europe 16, 26, 19, we 
found that women aged 20 and above had higher preva-
lent HSV-2 infection. This high prevalence in women 
is  similar to studies in Uganda where prevalence was 
about 50% 21 in the national survey, 86% and 62% in a 
clinic sample of  HIV-positive and HIV- negative preg-
nant women respectively 9.  Gender specific differences 
in HSV-2 infection have also been seen in Kenya and 
the Gambia 22, 27,28. Consistent data from many popula-
tions in sub Saharan Africa shows higher prevalence of  
HIV infection in women compared to men in popula-
tion samples29,30,31. Multivariable risk factors for preva-
lent HSV-2 infection (women, older age, low condom 
use, younger age at first sex and presence of  HIV infec-
tion were similar to earlier studies.18   Co-infection with 
HSV-2 and HIV has been documented in several stud-
ies22, 34.Kirakoya in addition to these risk factors, found 
an association between hormonal contraceptive use, 
bacterial vaginosis (BV) and incident HSV-2 infection 
35 in women.
The gender differences for HSV-2 and HIV may be ex-
plained in part by the biological susceptibility of  the 
female genital tract which makes women vulnerable to 
sexually transmitted diseases. Women may be vulner-
able to HIV and HSV-2 due to innate biological fac-
tors. The highly prevalent herpes among women may 
contribute too32 , as does the more efficient transmis-
sion of  HIV from men to women.  Probable increment 
in susceptibility of  genital mucosa in the presence of  
hormonal contraceptives in women due to reduction in 
normal bacteria in the tract has been proposed as an ex-
planation for the association between HSV-2 infection 
and contraceptive use 33 though hormonal contracep-
tive use may be a proxy for unprotected sexual inter-
course. The documented synergy of  HIV-1 and HSV-2 
infection; and of  contraceptives and HSV-2 infection 
in women in Africa, will need further exploration.  Re-
garding HSV-2/HIV co-infection, recent studies have 
shown that treatment with acyclovir for HSV-2 did not 
have an impact on reduction of  HIV transmission.6,36. 
A study by Zhu and colleagues showed that persistence 
and enrichment of  HIV receptor cells (CD-4 T-cells) 
may create a good environment for the entry, attach-
ment and dissemination of  HIV in persons who have 
HSV-2 infection with or without ulceration. HSV-2 re-
mains important for HIV transmission.
Socioeconomic factors may contribute to the gender 
disparity in prevalence of  HSV-2. Education level, usu-
ally lower in women in developing nations may be a 
co- factor to explain the higher prevalence in women38 
as number of  years in school is associated with safer 
sexual practices. 
 
The higher prevalence in women too, may be enhanced 
by disparities in access to sexual health care of  women 
in low income populations where cultural and social 
factors have been documented to influence access to 
care. Polygamy, increased number of  sexual partners 
especially among men, older age of  partners coupled 
with early sexual debut by girls as shown in this study 
may further contribute to the higher risk for HSV-2 and 
resultant prevalence in women.
There was a similarity in HSV-2 prevalence in the 15-19 
year categories for men and women, implying that this 
gender disparity in prevalence of  HSV-2 only emerges 
in the female age groups with time. The study found 
lower HSV-2 prevalence younger age groups, notably 
similar in boys and girls. The lower, similar prevalence 
in boys and girls 15-19 years of  age may present a win-
dow of  opportunity to prevent herpes infection onset 
in an age cohort in this population. Targeting younger 
boys and girls for prevention of  herpes could prevent 
new infections and enable potential control 39 and  re-
duce the upward trend of  HSV-2 prevalence. The nearly 
universal HSV-2 infection  in the above 40  age group 
and the reported older of  partner for young girls in this 
study, a phenomenon earlier documented in sub Saha-
ran Africa40, makes transmission likely to younger girls 
from older men. In turn, studies show younger girls 
also make sexual partnerships with younger boys 40, 41 
with resultant transmission into their peer group. 
 
Low prevalence of  syphilis in recent years has been 
documented elsewhere in Africa 42 and may be a result 
of  the intensive campaigns for treatment of  bacterial 
STDs.. We found little self-awareness of  genital herpes 
and an overwhelmingly inaccurate perception of  etiol-
ogy of  genital ulcer disease in this population. Educa-
tion on the high prevalence of  HSV-2 as opposed to 
syphilis and HSV-2’s atypical presentation for health 
workers and the population will be important to address 
this schism. Screening for HSV-2 is the best option but 
serological tests for genital herpes are still expensive. 
Community education may be of  most benefit. 
An earlier paper published with colleagues, comparing 
different cut-offs for the HerpeSelect2, suggests the use 
of  a 2.2 cut off12. However, this report uses the higher 
3.5 cut off. The higher cut-off  increases specificity for 
the HerpeSelect 2 ELISA.14,43,44
Limitations
Our study was limited in that distribution was skewed to 
women, despite return visits to increase men participa-
tion. We report a closely similar overall prevalence for 
the weighted analysis (weighted on 2002 Uganda census 
population distribution)  for men and women.  Anoth-
er study limitation was the absence of  a confirmatory 
HSV-2 Western blot. However, the higher cut off  point 
used increases the specificity of  the test. 
 
Conclusion
We reported high prevalence of  HSV-2 and of  HIV 
infection, especially among women in urban Kampala. 
HSV-2 infection was associated with being a woman, 
low condom use, early sexual debut. Prevalence in-
creased with age. Combined with a lack of  self  aware-
ness among those that they may be HSV-2 infected and 
with the high HIV prevalence, probability of  HSV-2 
transmission is high yet tests for herpes are limited to 
research settings in this community.
Health education on HSV-2 for health workers and the 
public is needed. A window of  opportunity for preven-
tion exists among the younger age groups. Behavioral 
interventions, especially in young women to delay sexu-
al debut, reduce number of  lifetime sexual partners and 
to increase consistent correct condom use could reduce 
HSV-2 incidence.  The synergistic relationship between 
HSV-2, HIV and needs further exploration. The rea-
sons underlying the divergence in gender specific preva-
lence with age, including contraception use also need 
further study. Cheaper, rapid tests for herpes simplex 
type 2 are needed. Since unaware, untested HSV-2 in-
fected persons may be mixing freely within the popula-
tion, the genital herpes epidemic may continue to grow 
in the absence of  strong public health measures. Tar-
geted public health engagement regarding HSV-2 in this 
population is crucial. 
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